Globe Newswire (Tue, 16-Apr 8:00 AM ET)
Globe Newswire (Mon, 15-Apr 8:00 AM ET)
Daxor’s Promising Growth and Innovation Outlook Merit a Buy Rating
TipRanks (Mon, 15-Apr 5:17 AM ET)
Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital
Globe Newswire (Wed, 10-Apr 8:00 AM ET)
Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24
Globe Newswire (Mon, 1-Apr 8:00 AM ET)
Globe Newswire (Mon, 25-Mar 8:00 AM ET)
Globe Newswire (Fri, 22-Mar 8:00 AM ET)
Globe Newswire (Mon, 18-Mar 2:18 PM ET)
Globe Newswire (Mon, 18-Mar 2:18 PM ET)
Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
Globe Newswire (Mon, 11-Mar 8:00 AM ET)
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Daxor - Closed End trades on the NASDAQ stock market under the symbol DXR.
As of April 19, 2024, DXR stock price declined to $9.60 with 601 million shares trading.
DXR has a market cap of $45.46 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, DXR stock traded as high as $15.46 and as low as $7.11.
The top ETF exchange traded funds that DXR belongs to (by Net Assets): VTI.
DXR has underperformed the market in the last year with a return of -15.8%, while the SPY ETF gained +22.0%. In the last 3 month period, DXR fell short of the market, returning -4.0%, while SPY returned +5.0%. However, in the most recent 2 weeks DXR has outperformed the stock market by returning +7.7%, while SPY returned -2.8%.
DXR support price is $9.34 and resistance is $10.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DXR stock will trade within this expected range on the day.